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The Lymphotoxin- Receptor Induces
Different Patterns of Gene Expression
via Two NF-B Pathways
quire LTR signaling for their expression in development
(Ngo et al., 1999; Luther et al., 2000; Vassileva et al.,
1999).
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mune responses, cell growth, and apoptosis (Barkett1Division of Cellular Immunology and
and Gilmore, 1999; Silverman and Maniatis, 2001). In2 Division of Molecular Immunology
mammals, this family consists of five members that formLa Jolla Institute for Allergy and Immunology
homo and heterodimeric complexes including NF-B110355 Science Center Drive
(p50 and its precursor p105), NF-B2 (p52 and its precur-San Diego, California 92121
sor p100), RelA (p65), RelB, and Rel (c-Rel). NF-B activ-3 Laboratory of Gene Regulation and Signal
ity is tightly controlled by a collection of inhibitory pro-Transduction
teins that belong to the IB family, which include IB,Department of Pharmacology
IB, IB, Bcl-3, p100, and p105 (Siebenlist et al., 1994).University of California San Diego
In most cells, the NF-B dimer p50:RelA is seques-La Jolla, California 92093
tered in the cytosol and its nuclear translocation can
be induced by a wide variety of stimuli. These stimuli
activate the IB kinase (IKK) complex, which containsSummary
two catalytic subunits, IKK and IKK, and the regula-
tory subunit IKK (also called NEMO) (DiDonato et al.,The lymphotoxin- receptor (LTR) plays critical roles
1997; Regnier et al., 1997; Rothwarf and Karin, 1999;in inflammation and lymphoid organogenesis through
Rothwarf et al., 1998; Woronicz et al., 1997; Yamaokaactivation of NF-B. In addition to activation of the
et al., 1998; Zandi et al., 1997), responsible for phosphor-classical NF-B, ligation of this receptor induces the
ylation of IB, IB, or IB (Karin and Ben-Neriah,processing of the cytosolic NF-B2/p100 precursor to
2000). The disruption of genes encoding individual IKKyield the mature p52 subunit, followed by translocation
subunits have demonstrated that IKK and IKK trans-of p52 to the nucleus. This activation of NF-B2 re-
mit the response to most common NF-B-inducingquires NIK and IKK, while NEMO/IKK is dispensable
agents, whereas IKK has an unexpected role in kera-for p100 processing. IKK-dependent activation of ca-
tinocyte differentiation (Hu et al., 1999, 2001; Li et al.,nonical NF-B is required for the expression but not
1999a, 1999b, 1999c; Makris et al., 2000; Rudolph et al.,processing of p100 and for the expression of proin-
2000; Takeda et al., 1999; Tanaka et al., 1999; Yamaokaflammatory molecules including VCAM-1, MIP-1, and
et al., 1998). IKK kinase activity is essential for induc-MIP-2 in response to LTR ligation. In contrast, IKK
tion of IB degradation in mammary epithelial cells incontrols the induction by LTR ligation of chemokines
response to RANK ligand (Cao et al., 2001) and in theand cytokines involved in lymphoid organogenesis,
basal processing of the NF-B2/p100 precursor to p52including SLC, BLC, ELC, SDF1, and BAFF.
in B lymphocytes (Senftleben et al., 2001). Processing of
p100 is negatively regulated by a processing-inhibitoryIntroduction
domain (PID) and positively regulated by the NF-B-
inducing kinase (NIK) (Xiao et al., 2001). Using an overex-
The lymphotoxin (LT)- receptor, a member of the TNF
pression system, Xiao and coworkers initially proposed
receptor superfamily, controls processes of differentia- that NIK is the direct upstream kinase involved in p100
tion crucial for the development and organization of processing. However, another study has shown that
lymphoid tissue (Locksley et al., 2001; Shakhov and NIK-induced p100 processing in B cells depends on
Nedospasov, 2001). Mice deficient in the LTR gene or IKK (Senftleben et al., 2001). The physiological regula-
genes encoding one of its ligands, LT or LT, exhibit tors of this pathway have not been described.
a complex phenotype characterized by a failure to form
lymph nodes and Peyers’s patches and the absence of Results
natural killer (NK) and NK-T cells (reviewed in Ansel and
Cyster, 2001; Fu and Chaplin, 1999). In the adult, LTR The Control of Gene Expression following
signaling is required for maintaining the splenic architec- Ligation of LTR
ture, the integrity of the marginal zone, and compart- We assessed the effect of LTR ligation on the expres-
mentalization of T and B cells. During antigen-depen- sion of several genes with roles in inflammation and
dent responses, germinal centers and networks of immune development using an agonistic, LTR-specific
follicular dendritic cell networks fail to form in LTR- monoclonal antibody (see Experimental Procedures).
deficient mice. Chemokines such as secondary lymphoid In mouse embryonic fibroblasts (MEF), this antibody
tissue chemokine (SLC/CCL21) and Epstein-Barr virus- induced the expression of the adhesion molecule
induced molecule 1 ligand (ELC/CCL19) play crucial VCAM-1, one of the known target genes downstream
roles in secondary lymphoid development and may re- of LTR (Matsumoto et al., 1999), induced by NF-B
(Shu et al., 1993) (Figure 1A). This effect was not seen
in MEFs lacking LTR.4 Correspondence: doug@liai.org
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Figure 1. LTR-Induced VCAM-1 Expression Depends on IKK and RelA but Not on NIK or IKK
(A) Ligation of LTR induces VCAM-1 mRNA upregulation. Wild-type and LTR-deficient MEFs were treated () or not (-) for 3 hr with 2 g/
ml of agonistic anti-LTR antibody prior to RNA extraction. VCAM-1 mRNA expression level was monitored by real-time PCR. Absolute
VCAM-1 mRNA values were determined and reported relative to the basal expression level detected in untreated LTR/ MEF.
(B) VCAM-1 mRNA expression is induced in aly/aly MEFS upon LTR ligation. Cells were treated as analyzed as described in (A).
(C) LTR-mediated VCAM-1 mRNA upregulation requires IKK and RelA. Wild-type, Ikk/, Ikk/, and rela/ MEFs were treated as in (A).
VCAM-1 mRNA expression level was monitored by real-time PCR. Absolute VCAM-1 mRNA values were determined and reported relative to
the basal expression level detected in untreated wt MEF.
Recently it was suggested that VCAM-1 expression 1/CCL4), macrophage inflammatory protein-2 (MIP-2),
secondary lymphoid tissue chemokine (SLC/CCL 21),is dependent on the function of NIK as cells from NIK
mutant aly/aly mice (Shinkura et al., 1999) did not upreg- EBI-1-ligand chemokine (ELC/CCL 19) B lymphocyte
chemoattractant (BLC/CXCL 13), and stromal cell-ulate this protein upon LTR ligation (Matsumoto et al.,
1999). We therefore examined the expression of VCAM-1 derived factor-1  (SDF-1-/CXCL 12) (Figures 2A and
2B). We also found that the B cell activation factor BAFFmRNA by real-time PCR in aly/aly MEFs. Ligation of
LTR induced increased expression of VCAM-1 mRNA (BlyS/TALL-1/THANK) (Moore et al., 1999) was upregu-
lated by ligation of LTR.(Figure 1B). In addition, anti-LTR induced IB-kinase
activity in both wt and aly/aly MEF (data not shown). Recently, a knockin mouse strain in which two serines
within the activation loop of IKK are replaced by ala-Therefore, the aly/aly mutation does not inhibit the ca-
nonical NF-B activation pathway that leads to expres- nines (IkkAA) was generated (Cao et al., 2001). Unlike
Ikk–/- animals, IkkAA mice are viable but show defectssion of this gene. The lack of upregulation of VCAM-1
by FACS in aly/aly cells observed by others (Matsumoto in basal processing of p100 to the p52 subunit of NF-
B2, the maturation of B lymphocytes, and the develop-et al., 1999), which we have also observed (data not
shown), may represent posttransciptional regulation of ment of lymphoid organs (Senftleben et al., 2001). In the
IkkAA knockin mice, the anti-LTR antibody failed toVCAM-1.
We therefore examined the expression of VCAM-1 stimulate the expression of SLC, ELC, BLC, SDF-1-,
or BAFF mRNA (Figure 2B). In contrast, the mutation inmRNA by real-time PCR in MEFs deficient for proteins
involved in NF-B activation. Ligation of LTR in wt the activation loop of IKK enhanced the upregulation
of MIP-1 and MIP-2 mRNAs following ligation of LTRMEFs induced a pronounced increase in expression of
VCAM-1 mRNA, which was not seen in cells lacking (Figure 2A). An increase in NF-B activity in these
knockin mice has been described (Senftleben et al.,IKK or RelA (Figure 1C). In contrast, constitutive ex-
pression of VCAM-1 mRNA was elevated in cells lacking 2001). Further, we observed that NFB2/p100 mRNA
was upregulated by ligation of LTR in the spleens ofIKK and this was substantially increased by ligation of
LTR. Therefore, induction of NF-B (p50:RelA) by anti- both wild-type and knockin IkkAA mice (Figure 2C).
LTR is responsible for the upregulation of VCAM-1
expression. Our results show that transcriptional induc- Ligation of the LTR Stimulates NIK- and
IKK-Dependent p100 Processingtion of VCAM-1 requires neither IKK nor NIK but does
require both IKK and RelA. The processing of p100 to p52 is an important step in
the activation of NF-B2. Therefore, wt and mutantWe then examined the effect of an intraperitoneal in-
jection of the agonistic anti-LTR antibody on expres- MEFs were treated with anti-LTR and the processing
of p100 was examined by immunoblotting. The low levelsion of several genes that are likely to be involved in
inflammation, lymphoid organ development, and ho- of constitutive processing of p100 to p52 was dramati-
cally enhanced by ligation of LTR in wild-type (wt) butmeostasis. The anti-LTR caused a significant upregula-
tion in the spleens of wt mice of the mRNA for the not LTR/ MEFs (Figure 3A). Recently, cells from NIK
mutant aly/aly mice were shown to lack spontaneouschemokines macrophage inflammatory protein-1 (MIP-
Distinct NF-B Signaling Pathways Induced by LTR
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Figure 2. Expression of Chemokines and Cytokine in Wild-Type and IkkAA Knockin Splenocytes following Intraperitoneal Injection of Agonistic
Anti-LTR Antibody
Wild-type (n 	 3) and IkkAA knockin (n 	 3) mice were injected intraperitoneally (as described in Experimental Procedures) with an isotype
control antibody (-) or with an agonistic LTR antibody (). RNAs were isolated from spleens, reverse-transcribed, and analyzed by real-time
PCR for (A) inflammatory chemokines MIP-1 and MIP-2; (B) for chemokines SLC, ELC, and the cytokines SDF-1 and BAFF; and (C) for NF-
B2/p100. For each gene, absolute mRNA values were determined and reported relatively to the basal expression (-) detected in wt IKK
mice. One representative experiment out of three is shown.
processing of p100 to p52 (Xiao et al., 2001), and ligation B cells from mice with a knockin mutation of IKK
(IKKAA mice) show a reduced constitutive processingof the LTR on aly/aly MEFs failed to induce the pro-
cessing of p100 to p52 (Figure 3A). Therefore, the aly of p100 (Senftleben et al., 2001). Ikk/ MEFs were
therefore reconstituted with retroviral expression vec-mutation appears to affect both basal and LTR-
induced processing of p100. tors encoding wt IKK or the IKK mutant harboring the
point mutations S176A and S180A in the activation loopThis effect of ligation of LTR was not restricted to
MEF. In the human colon carcinoma cell line HT-29, (IKKAA) (Delhase et al., 1999) and stable lines were se-
lected for GFP expression. In each case the stably trans-ligation of LTR with an agonistic antibody for human
LTR or with the ligand LT2 also resulted in the induc- duced lines expressed similar amounts of IKK protein
(Figure 3E) and cell-surface LTR by FACS (data nottion of processing of p100 to p52 (Figure 3B). This was
inhibited by the proteasome inhibitor MG-132 (Xiao et shown). Ikk/ cells showed neither constitutive nor
LTR-induced p100 processing, while reconstitutional., 2001) but not by the caspase inhibitor zVAD-fluoro-
methylketone. with wt IKK restored this activity (Figure 3E). However,
the IKKAA mutant did not, indicating that activation ofCytokine-induced NF-B activation is mediated by a
high molecular weight IKK complex composed of IKK, IKK by phosphorylation within the T loop is required
for the LTR-induced of p100 processing.IKK, and NEMO/IKK. Using cells genetically deficient
in these components (Hu et al., 1999; Li et al., 1999c, Further, MEF lacking wt IKK showed an increased
level of p100 expression 24 hr after LTR ligation (Fig-2000; Makris et al., 2000), we examined their respective
roles in the induction of processing of p100 to p52 fol- ures 3C and 3E), consistent with the observations on
p100 expression after in vivo administration of anti-LTRlowing ligation of LTR. Anti-LTR stimulated the pro-
cessing of p100 to p52 in wt MEFs but not in MEFs (Figure 2C). Thus, while IKK and RelA participate in the
regulation of the level of p100 available for processinglacking IKK (Figure 3C). Examination of the processing
of p100 in wt MEFs suggests that new synthesis of p100 to p52, IKK is dispensable for the induction of p100
processing in response to ligation of LTR. IKK, how-contributes to the increased accumulation of p52, and
this was not seen in the cells lacking IKK. Nevertheless, ever, is required for the induction of this processing
event.in MEFs lacking IKK, the p100 was almost completely
processed by 24 hr after ligation of LTR. This pattern
is consistent with NF-B2 as a NF-B target gene (Liptay LTR Ligation Induces Nuclear Translocation
of RelB-p52 and RelA-p52et al., 1994), as the activation of NF-B depends on
IKK. Indeed, ligation of LTR in MEFs lacking RelA As previously reported (Dejardin et al., 1998; Dobrzanski
et al., 1995), RelB is mainly sequestered by the inhibitor(rela/) failed to induce the accumulation of NF-B2
although the processing of p100 remained intact (Figure p100, but the physiological signals that control RelB
expression and nuclear translocation are still poorly3D). This was the same pattern of p100 processing as
was seen in MEFs lacking IKK (Figure 3C). characterized. We therefore examined the nuclear trans-
Immunity
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Figure 3. NIK and IKK Are Required for the Inducible p100 Processing through Activation of the LTR
(A) NIK is involved in LTR-mediated p100 processing. Embryonic fibroblasts from LTR/, wild-type, or aly/aly mice were treated with an
agonistic LTR antibody (2 g/ml) for 0, 8, or 24 hr. Whole cell extracts were separated by SDS-PAGE and p100/p52 proteins were analyzed
by immunoblotting using an amino-terminal p52:p100-specific antibody.
(B) p100 processing is inhibited by the proteasome inhibitor MG-132 but not by the caspase inhibitor ZVAD. HT-29 cells were treated with a
human LTR agonistic antibody (1 g/ml) for 0, 3, or 6 hr in the presence or absence of MG-132 or zVAD-fmk. Whole cell extracts were
analyzed as in (A).
(C) IKK but not IKK is required to trigger p100 processing. Embryonic fibroblasts from wild-type, Ikk/, Ikk/, or Ikk/ Ikk/ mice
were treated and analyzed as described in (A).
(D) RelA is involved in the sustained production of p100 following LTR ligation. Embryonic fibroblasts from rela/ mice were treated and
analyzed as described in (A).
(E) LTR-induced p100 processing requires activation of IKK. Embryonic fibroblasts from IKK-deficient mice were infected with either an
IRES-GFP control retrovirus or an IRES-GFP retrovirus expressing either wt IKK or the mutant IKKAA. Stably infected cells were sorted by
FACS to
95% GFP-expressing cells. Cells were treated with agonistic anti-LTR (2 g/ml) and cell extracts were subjected to immunoblotting.
location of RelB and p52 following ligation of the LTR. the 1 hr extracts with antibody to RelA reduced (super-
shifted) the band indicated by the upper (filled) arrow inThe levels of RelB and p52 in the nucleus increased
within 1–2 hr after LTR ligation and continued to accu- Figure 5A; this was not seen with antibody to RelB, and
only slightly with antibody to p52. In contrast, at 6 hrmulate over 24 hr (Figure 4A). In addition, the overall
level of RelB expression increased following stimulation this band was effectively supershifted with antibodies
to p52, RelA, or RelB.with anti- LTR. In contrast, RelA translocated to the
nucleus within 1–2 hr of anti-LTR treatment and then To determine whether RelA or RelB associate with
p52, cytosolic and nuclear extracts from HT29 were pre-decreased, while in LTR/ MEFs RelA and RelB re-
mained in the cytosol (data not shown). The same pat- cipitated with anti-RelA or -RelB antibodies and immu-
noblotted for p52 (Figure 5B). After 1 hr ligation of LTR,terns of nuclear translocation of NF-B subunits were
also seen upon LTR ligation in HT29 cells (data not p52 was found in association with RelA in the nucleus;
after 6 hr ligation p52 was found in association with RelB,shown). The upregulation and translocation of RelB in
response to LTR-ligation occurred in Ikk/ MEFs, consistent with the patterns of nuclear translocation of
each of these proteins (Figure 5C). Conversely, immuno-but not in MEFs lacking IKK (Figure 4B).
The DNA binding activity of the nuclear NF-B com- precipitation of p52 from nuclear extracts coprecipitated
with RelA and RelB at the appropriate time points (dataplexes was analyzed by electromobility shift assay (Fig-
ure 5A). Nuclear extracts from untreated HT29 cells con- not shown). Therefore, while we suspect that RelA is
associated predominantly with p50 after ligation of LTRtained only low levels of NF-B DNA binding activity,
which increased after 1 or 6 hr of treatment with agonis- as described by others (Force et al., 2000), the p52
that translocates to the nucleus following LTR ligationtic anti-LTR antibody, and this binding was effectively
competed with unlabeled oligonucleotide. Treatment of appears to associate with both RelA and RelB.
Distinct NF-B Signaling Pathways Induced by LTR
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Figure 4. Nuclear Translocation of p52 and
RelB Is Dependent on IKK but Not on IKK
(A) Ligation of LTR triggers p52, RelB, and
RelA nuclear translocation. Mouse embryonic
fibroblasts were treated with an agonistic
LTR antibody for the indicated period of
time. Cytoplasmic and nuclear extracts were
prepared as previously described (Dejardin
et al., 1995) and analyzed by immunoblotting
for p100:p52, RelB, and RelA proteins. As
control for cytoplasmic contamination in the
nuclear fractions, we used an anti-Hsp60
antibody.
(B) LTR ligation-induced RelB nuclear trans-
location and RelB protein level upregulation
are IKK dependent but IKK independent.
Embryonic fibroblasts from Ikk/ and
Ikk/ mice were treated as described in (A)
and analyzed for RelB protein expression in
both cytoplasmic and nuclear fractions.
Interestingly, nuclear p100 (also seen in Figure 4) co- To determine if all three proteins can form a complex,
the precipitated NIK was eluted with flag peptide andprecipitated with RelB but not with RelA (Figure 5B).
This is consistent with a recent report that p100 may the released proteins were then bound to anti-IKK. The
p100 coprecipitated with IKK under these conditionsfunction in nuclear export of RelB (Solan et al. 2002).
(Figure 6D), indicating that it was in a complex with both
NIK and IKK. While we do not know if this complex
C-Terminal Phosphorylation of p100 following forms physiologically, it raises the possibility that a NIK-
Ligation of LTR by an IKK-Associated IKK-p100 complex is involved in the activation of
Kinase Activity NF-B2 independently of IKK.
In most cultured cell types, IKK and IKK are predomi-
nantly found in equimolar ratios within a high molecular
weight IKK complex that also contains IKK (Rothwarf Discussion
et al., 1998). To determine if ligation of LTR activates
IB and p100 kinase activities, cytoplasmic extracts Here we have studied the signaling events mediated by
ligation of the LTR that lead to the expression of genesfrom MEFs stimulated for 0, 15, or 180 min with agonistic
anti-LTR antibody or with TNF were prepared. Extracts involved in inflammation and secondary lymphoid or-
ganogenesis and homeostasis (Figure 7). We have ob-were immunoprecipitated with anti-IKK and phosphor-
ylation of IB and p100 were assessed. As shown in served that the induction of these genes occurs via
the activation of two NF-B pathways: the formation ofFigure 6A, both TNF and anti-LTR triggered IKK kinase-
mediated IB phosphorylation. In contrast, the ligation p50:RelA heterodimers and the processing of the NF-
B2 gene product p100 to active p52.of LTR but not the TNFR induced IKK-associated
p100 kinase activity (Figure 6B). The conversion of p100 to p52 has been shown to
be negatively controlled by a C-terminal processing-Treatment of IKK-deficient MEFs with agonistic anti-
LTR antibody also led to p100 kinase activity (Figure inhibitory domain of p100 and activated by phosphoryla-
tion, with subsequent ubiqutination and degradation by6C). Interestingly, the activation of the IKK-associated
p100 kinase activity and p100 processing were elevated the proteasome (Xiao et al., 2001). In that study, overex-
pression of either LTR and/or NIK in HEK 293T cellsin cells lacking IKK. Moreover, despite the absence of
IKK, ligation of LTR further increased p100 pro- resulted in p100 processing. Our observation that LTR
ligation leads to p100 processing in wt but not NIK mu-cessing. In each case, the activation of p100 kinase
activity preceded the appearance of processed p100. tant aly/aly MEFs is consistent with these results. Subse-
quent studies have demonstrated that NIK-inducedTo gain insights into the possible complex responsible
for p100 phosphorylation, 293T cells were transfected p100 processing is IKK dependent (Senftleben et al.,
2001). Here we have shown that LTR-induced p100with expression constructs for flag-NIK, HA-IKK, and/
or HA-p100. Precipitation of NIK with anti-flag coprecipi- phosphorylation and processing are dependent on IKK
but independent of IKK. In addition, we have nowtated IKK and p100, as expected from other studies
(Matsushima et al., 2001; Xiao et al., 2001) (Figure 6D). shown that IKK is dispensable for p100 processing. The
Immunity
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Figure 5. LTR Ligation Induces Distinct p52-Containing Complexes
(A) DNA binding activity of NF-B complexes following LTR ligation. HT29 cells were treated with an agonistic anti-human LTR antibody
(10 g/ml) for the indicated times and nuclear extracts were prepared and analyzed by electromobility shift assay for NF-B binding activity.
For supershift, samples were incubated with the indicated antibody prior to incubation with the labeled probe. Arrowheads show the NF-B
complexes.
(B) Identification of p52:RelA and p52:RelB complexes. HT29 cells were treated with agonistic anti-human LTR antibody as in (A). Cytosolic
(cyt.) and nuclear (nucl.) extracts were subjected to immunoprecipitation with anti-RelA or anti-RelB antibody and analyzed for associated
p52/p100 by immunoblot. C, control extract; C Ab, immunoprecipitation of control cytostolic extract with control antibody.
(C) Nuclear translocation of p52, RelA, and RelB after LTR ligation The cytosolic and nuclear extracts from the experiment shown in (B) were
immunoblotted for the indicated proteins.
elevated p100 processing we observed in the absence of compartments. Although T and B cells develop normally
and populate the spleen, during antigen-dependent re-IKK may be a consequence of an increase in IKK
kinase activity as proposed previously (May et al., 2000). sponses germinal centers do not form and networks of
follicular dendritic cells fail to form in LTR-deficientAlthough the absence of IKK/NEMO or the disruption
of the interaction between IKK/NEMO and IKKs prevent mice (Futterer et al., 1998).
Similarly, animals lacking p100/p52 show a markedTNF-induced IB kinase activity (Makris et al., 2000; May
et al., 2000), ligation of LTR nevertheless induces p100 reduction in the B cell compartments of the spleen,
bone marrow, and lymph nodes, and display an alteredphosphorylation in the absence of IKK/NEMO. This
provocative result suggests that IKK/NEMO is not a splenic and lymph node architecture, lacking B cell folli-
cles and germinal centers (Caamano et al., 1998;universal integrator for all NF-B signaling pathways
and it is possible that other IKK complexes exist. Franzoso et al., 1998). Mice deleted for RelB are also
unable to form germinal centers upon antigen challengeAnimals lacking LT, LT, LTR, or NIK have severe
defects in secondary lymphoid organogenesis (Alimzha- and display abnormal splenic architecture (Burkly et al.,
1995; Weih et al., 1995). In addition, animals deficientnov et al., 1997; Banks et al., 1995; De Togni et al., 1994;
Futterer et al., 1998; Koni et al., 1997; Yin et al., 2001). in IKK have defects in secondary lymphoid tissue, es-
pecially in Peyer’s patch development, germinal centerThis phenotype includes an absence of lymph nodes,
Peyer’s patches, germinal centers, and a disorganized formation, and B cell development (Kaisho et al., 2001;
Matsushima et al., 2001; Senftleben et al., 2001).splenic architecture. In the adult, LTR signaling is re-
quired for maintaining the architecture of the white pulp Cytokine-induced NF-B activation through IBdeg-
radation does not require IKK kinase activity and in-in the spleen and is necessary for integrity of the mar-
ginal zone and segregation of T and B cells into discrete stead is dependent on IKK (Delhase et al., 1999; Hu et
Distinct NF-B Signaling Pathways Induced by LTR
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Figure 6. LTR Ligation Induces p100 Processing through an IKK-Containing Complex
(A) LTR induces IB- kinase activity. Wild-type MEFs were treated for the indicated period of time with TNF (0.5 nM) or agonistic LTR
antibody (2 g/ml). Cell extracts were subjected to immunoprecipitation with either anti-IKK antibodies or anti-IKK antibody prior to kinase
assays using a GST-IB- 1-54 substrate.
(B) LTR but not TNFRI signals through IKK to trigger p100 phosphorylation. Wild-type and IKK-deficient MEFs were stimulated as described
in (A). Cell extracts were subjected to IKK immunoprecipitation prior to kinase assays with a GST-p100 substrate.
(C) IKK is dispensable for LTR-mediated p100 phosphorylation and processing. Wild-type and IKK-deficient embryonic fibroblasts were
treated for the indicated period of time with 2 g/ml of agonistic anti-LTR. Cell extracts were immunoprecipitated with anti-IKK antibodies
and used for kinase assays with a GST-p100 substrate. The same extracts were analyzed by Immunoblotting to detect IKK and p100:p52
protein expression.
(D) NIK, IKK, and p100 can form a complex. 293T cells were transfected with constructs for expression of flag-NIK, HA-IKKa, and/or HA-
p100, as indicated. Total expression of the proteins in whole cell extracts (WCE) is shown in the upper panel. In the lower panel, extracts
were precipitated with anti-flag and tagged proteins detected by immunoblot with anti-HA antibody. In the lane on the far right, protein was
precipitated with anti-flag, then eluted by incubation with flag peptide. The supernatants were then immunoprecipitated with anti-IKK, and
tagged proteins were detected by immunoblot with anti-HA antibody.
al., 1999; Li et al., 1999a; Takeda et al., 1999). Con- Using mice with a knockin mutation within the T loop
domain of IKK (Cao et al., 2001), we observed thatversely, the processing of p100 is dependent on IKK
kinase activity but not on IKK (Senftleben et al., 2001). IKK activation is also required for LTR-induced ex-
Immunity
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Figure 7. Model for Lymphotoxin- Receptor-Mediated NF-B Activation
Upon LTR ligation, two NF-B activating pathways are engaged. The first leads to activation of IKK and RelA, which control expression of
inflammatory genes such as VCAM-1, MIP-1, and MIP-2. In addition, this pathway leads to an increase of NF-B2/p100 precursor. The
processing of the latter is controlled by a second pathway that involves the activation of NIK which in turn activates IKK for generating
active p52. p52 in association with its partners (e.g., RelB) translocates to the nucleus and activates the transcription of genes implicated in
secondary lymphoid organogenesis and homeostasis such as SLC, ELC, BLC, SDF-1, and BAFF.
pression of the chemokines ELC, SLC, BLC, and SDF- not shown). A defect in B cells observed in the latter
animals appears around 9 weeks and becomes signifi-1- and the cytokine BAFF (Figure 2). SLC and ELC act
via the CCR7 receptor and have been shown to have cant 12 weeks after bone marrow transfer (Senftleben
et al., 2001), and may therefore be due to signalingimportant functions in lymphoid homing to secondary
lymphoid tissues (Forster et al., 1999; Gunn et al., 1999; defects that are distinct from those of the LTR. In addi-
tion, and apart from these considerations, the cell typesNgo et al., 2001; Reif et al., 2002). Similarly, it has been
observed that expression of SLC and ELC, which play responsible for LTR-ligation-dependent cytokine and
chemokine production in the spleen have yet to be defin-important roles in the organization of lymphoid organs,
is reduced in p52 and RelB-deficient mice (Weih et al., itively determined, as this receptor has been identified
on both stromal and myeloid cells (Browning and2001). SDF-1 plays roles in the early stages of B cell
development (Egawa et al., 2001; Luther et al., 2000). In French, 2002).
Recent evidence has shown that although tnfrI/addition, BAFF has a critical role in B cell development,
in the formation of germinal centers, and in B cell survival mice have minor defects in splenic architecture and
Peyer’s patch development (Neumann et al., 1996),(Batten et al., 2000; Schiemann et al., 2001). The ability
of LTR to stimulate production of these mediators is tnfrI/ rela/ mice lack the same secondary lymphoid
organs and structures that are absent in LTR-deficientconsistent with its role in secondary lymphoid organo-
genesis and homeostasis. mice (Alcamo et al., 2001, 2002; Futterer et al., 1998).
In contrast, animals lacking p50 do not show these de-It is therefore tempting to conclude that the NF-B2
signaling pathway we have described links the LTR velopmental defects (Sha et al., 1995). Therefore, the
RelA-p52 complex that we have observed following liga-receptor to critical chemokines and cytokines that ac-
count for the phenotypes of the knockouts discussed tion of LTR (Figure 5B) may be important in at least
some of the IKK-dependent gene expression requiredabove. However, this is probably overly simplistic. IKK
plays important roles in signaling from receptors other for organogenesis. However, the ability of RelA to induce
p100 mRNA upregulation required for a sustained p52than LTR; for example, B cells (which lack LTR) show
IKK-dependent p100 processing (Senftleben et al., production (Figures 2 and 3) may also play a significant
role in LTR-mediated lymphoid organogenesis.2001). Further, IKK can function in the activation of
conventional NF-B as well (Cao et al., 2001). Several It may also be that p52:RelB, induced by LTR, tem-
pers the inflammatory effects of LTR-mediated signal-of the chemokines and cytokines we have examined
may be produced in response to signals distinct from ing pathways, such as the canonical NF-B activation
pathway. We observed that the ability of ligated LTR tothose of the LTR -IKK - NF-B2 pathway we have
discussed. For example, as in LTR-deficient animals, induce the expression of the inflammatory chemokines
MIP-1 and MIP-2 was enhanced in animals lackingwe observed normal numbers of CD3 and CD19 cells
in the spleens of 5-week- old knockin IkkAA mice (data inducible IKK kinase activity (Figure 2). Interestingly,
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Cell Culture and Cell LinesRelB-deficient mice display a generalized inflammation
Embryos from LTR/ (from Klaus Pfeffer, University of Munich,(Burkly et al., 1995; Weih et al., 1996). Thus, p52:RelB,
Munich, Germany) and Nikaly/aly (from CLEA Japan, Osaka, Japan)induced by LTR, may function in the repression of
mice were used to prepare MEFs, expanded for two passages before
these and other inflammatory chemokines. Therefore, doing an assay. IKK, IKK, and IKK-deficient cells were described
the interplay of the different NF-B pathways engaged (Hu et al., 1999; Li et al., 1999c; Makris et al., 2000). MEF were
cultured in DMEM (Gibco BRL) supplemented with 10% heat-inacti-by ligation of LTR may be complex and contribute to
vated FCS, 2 mM L-glutamine, 1 mM sodium pyruvate, 100 U/mlinflammation and immune development in diverse ways.
penicillin, and 100 g/ml streptomycin. HT29 (ATCC) was cultured
in McCoy’s 5a with the same supplements.
Experimental Procedures
Reagents and AntibodiesPlasmid Constructs and Retrovirus Gene Transfer
MG-132 and PNPP were from Calbiochem, zVAD-fmk was fromWild-type human Ikk and mutant IkkAA (Delhase et al., 1999) were
Enzyme Systems Products. Recombinant human lymphotoxin 12cloned into pMX-IRES-GFP retroviral vector. The following primers
was from R&D Systems Inc.. Antibodies were from Imgenex (IKK),were used to PCR amplify human IKK: S-5-TATAGAATTCATG
Upstate Biotech. Inc. (p52:p100), Pharmingen (IKK), Santa-CruzGAGCGGCCCCCGGGG-3 and AS- 5-TATAGTCGACTCATTCTGT
(RelA, RelB, p100/p52, NIK, IKK), ICN (actin) and StressGenTAACCAACTCC-3. PCR products were digested with EcoRI and
(Hsp60). The anti-p52:p100 polyclonal antibody was generously pro-SalI and cloned into the retroviral vector digested with EcoRI-XhoI.
vided by J. Hiscott and N. Rice (Pepin et al., 1994).Retroviral constructs in combination with the pEC-ampho expres-
sion vector were transfected by the calcium phosphate method into
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